EichorEICHOR
Location: Danville Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Danville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

BioHealx® Anal Fistula Device Post Market Surveillance Study
Phase N/A · Geisinger · Signum Surgical USA Inc. · NCT07021742
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT05564390
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT05099003
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT06172296
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05624996
M-Vizion™ Macroscopic Radiographic Study
Phase N/A · Geisinger Medical Center · Medacta USA · NCT05721859
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0143 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT07321652
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT05691478
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT07091617
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Geisinger Medical Center · PrECOG, LLC. · NCT06538038
Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Geisinger Medical Center · Sequenom, Inc. · NCT06643741
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Geisinger Medical Center · Children's Oncology Group · NCT04322318
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05946213
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Carle at The Riverfront · NRG Oncology · NCT06532279
Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations
Phase N/A · Geisinger Medical Center · National Institute of Mental Health (NIMH) · NCT04639830
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05174169
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06632327
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06931340
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Phase N/A · Geisinger Health System · The Radiosurgery Society · NCT01885299
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06876714
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · Geisinger Medical Center · Canadian Cancer Trials Group · NCT03550391
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT04269902
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Geisinger Medical Center · Canadian Cancer Trials Group · NCT06592924
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Geisinger Medical Center · Children's Oncology Group · NCT04293562
E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Carle at The Riverfront · NRG Oncology · NCT06748222
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress
Phase 2 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT06649812
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Geisinger Medical Center · NRG Oncology · NCT03180268
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · Sovah Clinical Research-River District · Eli Lilly and Company · NCT07589608
Look up another city
Look up another condition